Technology | May 04, 2009

UltraSPECT Introduces the Xpress3.Cardiac Image Reconstruction in U.S.

May 4, 2009 –UltraSPECT said April 30 it intends to offer the Xpress3.Cardiac SPECT WBR-based SPECT image reconstruction package for sale in the U.S., which the company said enables short acquisition times with good resolution.

The Xpress3.Cardiac reportedly enables short scan times without compromising image quality and diagnostic confidence. The company said the scan times are three minutes for stress and less than five minutes for rest. The Xpress3.Cardiac was FDA cleared in May of 2008 and was showcased at the ASNC 2008 Annual Meeting last September in Boston. The product has since been in routine clinical use at a limited number of sites in the U.S. and Europe, including St. Luke's Roosevelt Hospital in New York City, Mayo Clinic, Duke University Medical Center, Baptist Hospital of Miami, and Atlanta Heart Specialists.

The Xpress3.Cardiac is fully automatic, with a single processing protocol for all patients. The hardware platform is based on a quad-core CPU, which can be connected to the gamma camera and workstation network in a matter of hours. The company said this enables quarter-time image acquisition with reconstructions that are the same or better than using standard imaging times. UltraSPECT said there is no extra work required of the technologist, as the image reconstruction process is completely transparent to the department's clinical workflow.

The Xpress3.Cardiac, along with UltraSPECT’s Xpress.Cardiac and Xpress/Xact.Bone products, are exclusively distributed in the U.S. by Cardinal Health.

For more information: www.ultraspect.com

Related Content

News | Computed Tomography (CT) | May 21, 2018
The Istituto Oncologico Veneto (IOV) in Padua, Italy, has acquired MILabs’ latest-generation Versatile Emission...
The Chalk River nuclear reactor license has been renewed, but will be decommissioned by 2028.

The Chalk River nuclear isotope reactor license has been renewed, but will be decommissioned by 2028. The reactor supplies about 50 percent of the world's supply of Tc99m.

Feature | Nuclear Imaging | April 02, 2018 | Dave Fornell
April 2, 2018 – The Canadian Nuclear Safety Commission (CNSC) announced March 29 that it renewed Canadian Nuclear Lab
A Tc99m SPECT cardiac exam showing myocardial perfusion in the heart.

Technetium-99m is primarily used for the detection of cancer and to assess perfusion defects in the heart caused by heart attacks or other conditions.

Feature | Radiopharmaceuticals and Tracers | February 08, 2018 | Dave Fornell
February 8, 2018 — The U.S.
Philips Launches CardioMD IV Cardiac SPECT Solution at ASNC 2017
Technology | SPECT Imaging | September 15, 2017
September 15, 2017 — Philips highlighted its newest solution for...
Videos | Nuclear Imaging | August 24, 2017
Prem Soman, M.D., director of nuclear cardiology at the Heart and Vascular Institute, University of Pittsburgh, and p
Videos | Nuclear Imaging | August 24, 2017
Randy Thompson, M.D., attending cardiologist, St.
advanced visualization
News | Molecular Imaging | June 09, 2017
The Food and Drug Administration (FDA) has cleared syngo.via VB20 for Molecular Imaging (MI) from Siemens Healthineers...
News | SPECT-CT | June 08, 2017
Siemens Healthineers debuts Symbia Intevo Bold at the 2017 annual meeting of the Society of Nuclear Medicine &...
Videos | Nuclear Imaging | April 28, 2017
David Wolinsky, M.D., director of nuclear cardiology at Cleveland Clinic Florida and past-president of the American S
SPECT/CT Imaging Test Shown Accurate in Ruling Out Kidney Cancers
News | SPECT Imaging | April 24, 2017
The latest in a series of studies led by researchers at Johns Hopkins Medicine shows that addition of a widely...
Overlay Init